Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors

Objective: Vaccination for SARS-CoV-2 provides significant protection against the infection in the general population. However, limited data exist for cancer patients under systemic therapy. Methods: In this cohort, we prospectively enrolled cancer patients treated with PARPi as well as healthy volu...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Vaccines
المؤلفون الرئيسيون:	Michalis Liontos, Evangelos Terpos, Christos Markellos, Flora Zagouri, Alexandros Briasoulis, Ioanna Katsiana, Efthymia Skafida, Oraianthi Fiste, Elena Kunadis, Angeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios-Athanasios Dimopoulos
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2021-10-01
الموضوعات:	ovarian cancer SARS-CoV-2 vaccination PARP inhibitors
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/9/10/1148